Literature DB >> 7009653

Tolerance to the humoral and hemodynamic effects of caffeine in man.

D Robertson, D Wade, R Workman, R L Woosley, J A Oates.   

Abstract

Acute caffeine in subjects who do not normally ingest methylxanthines leads to increases in blood pressure, heart rate, plasma epinephrine, plasma norepinephrine, plasma renin activity, and urinary catecholamines. Using a double-blind design, the effects of chronic caffeine administration on these same variables were assessed. Near complete tolerance, in terms of both humoral and hemodynamic variables, developed over the first 1-4 d of caffeine. No long-term effects of caffeine on blood pressure, heart rate, plasma renin activity, plasma catecholamines, or urinary catecholamines could be demonstrated. Discontinuation of caffeine ingestion after 7 d of administration did not result in a detectable withdrawal phenomenon relating to any of the variables assessed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7009653      PMCID: PMC370671          DOI: 10.1172/jci110124

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Effects of xanthine derivatives on lipolysis and on adenosine 3',5'-monophosphate phosphodiesterase activity.

Authors:  J A Beavo; N L Rogers; O B Crofford; J G Hardman; E W Sutherland; E V Newman
Journal:  Mol Pharmacol       Date:  1970-11       Impact factor: 4.436

2.  The influence of analeptic drugs on the pontine vasomotor center.

Authors:  M G Bondaryóv
Journal:  Nurs Mirror Midwives J       Date:  1967-04-28

3.  Electromechanical and pharmacomechanical coupling in vascular smooth muscle.

Authors:  A V Somlyo; A P Somlyo
Journal:  J Pharmacol Exp Ther       Date:  1968-01       Impact factor: 4.030

4.  The syndrome of essential hypertension and suppressed plasma renin activity. Normalization of blood pressure with spironolactone.

Authors:  R M Carey; J G Douglas; J R Schweikert; G W Liddle
Journal:  Arch Intern Med       Date:  1972-12

5.  The tolerance of coffee drinkers to caffeine.

Authors:  T Colton; R E Gosselin; R P Smith
Journal:  Clin Pharmacol Ther       Date:  1968 Jan-Feb       Impact factor: 6.875

6.  Release of norepinephrine in the central nervous system by theophylline and caffeine.

Authors:  B A Berkowitz; J H Tarver; S Spector
Journal:  Eur J Pharmacol       Date:  1970-04       Impact factor: 4.432

7.  Effect of caffeine and theophylline on peripheral catecholamines.

Authors:  B A Berkowitz; S Spector
Journal:  Eur J Pharmacol       Date:  1971-01       Impact factor: 4.432

8.  Psychotropic effects of caffeine in man. IV. Quantitative and qualitative differences associated with habituation to coffee.

Authors:  A Goldstein; S Kaizer; O Whitby
Journal:  Clin Pharmacol Ther       Date:  1969 Jul-Aug       Impact factor: 6.875

9.  Psychotropic effects of caffeine in man. 3. A questionnaire survey of coffee drinking and its effects in a group of housewives.

Authors:  A Goldstein; S Kaizer
Journal:  Clin Pharmacol Ther       Date:  1969 Jul-Aug       Impact factor: 6.875

10.  Mechanism of potentiation of contractor responses to catecholamines by methylxanthines in aortic strips.

Authors:  S Kalsner
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

View more
  88 in total

Review 1.  Genetics of caffeine consumption and responses to caffeine.

Authors:  Amy Yang; Abraham A Palmer; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2010-06-09       Impact factor: 4.530

Review 2.  Caffeine and endurance performance.

Authors:  M A Tarnopolsky
Journal:  Sports Med       Date:  1994-08       Impact factor: 11.136

3.  Central and peripheral effects of sustained caffeine use: tolerance is incomplete.

Authors:  Joanne Watson; Ian Deary; David Kerr
Journal:  Br J Clin Pharmacol       Date:  2002-10       Impact factor: 4.335

Review 4.  A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features.

Authors:  Laura M Juliano; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2004-09-21       Impact factor: 4.530

Review 5.  Energy beverages: content and safety.

Authors:  John P Higgins; Troy D Tuttle; Christopher L Higgins
Journal:  Mayo Clin Proc       Date:  2010-11       Impact factor: 7.616

6.  Effects of caffeine with repeated dosing.

Authors:  C P Denaro; C R Brown; P Jacob; N L Benowitz
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

7.  Coffee consumption and the incidence of type 2 diabetes in men and women with normal glucose tolerance: the Strong Heart Study.

Authors:  Y Zhang; E T Lee; L D Cowan; R R Fabsitz; B V Howard
Journal:  Nutr Metab Cardiovasc Dis       Date:  2010-02-18       Impact factor: 4.222

Review 8.  Caffeine and endurance performance.

Authors:  S K Powers; S Dodd
Journal:  Sports Med       Date:  1985 May-Jun       Impact factor: 11.136

Review 9.  Caffeine and ephedrine: physiological, metabolic and performance-enhancing effects.

Authors:  Faidon Magkos; Stavros A Kavouras
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 10.  Pharmacological rationale for the clinical use of caffeine.

Authors:  J Sawynok
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.